|

Improving Muslim Women's Uptake of Cancer Screening (IMCAN)

RECRUITINGN/ASponsored by University of Sunderland
Actively Recruiting
PhaseN/A
SponsorUniversity of Sunderland
Started2023-11-01
Est. completion2025-10
Eligibility
Age25 Years – 74 Years
SexFEMALE
Healthy vol.Accepted

Summary

The goal of this non-randomised trial is to test how a workshop that includes religiously-tailored messages can help increase the uptake of breast, colorectal and cervical cancer screening among Muslim women in North East England and Scotland. The results of this trial will inform the development of a full-scale randomised-controlled trial. Participants in this study will be asked to take part in a two-hour workshop, deliver either online or in-person.

Eligibility

Age: 25 Years – 74 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Women from any ethnicity identifying as Muslim
* Muslim Women aged 25-74 years
* Muslim women living in North East England or Scotland
* Muslim women who are not up-to-date with all cancer screening they are eligible for; women who are up-to-date with one type of screening but not others would be eligible (for example, women might be up-to-date with breast cancer screening but not cervical or bowel cancer screening)

Exclusion Criteria:

* Women who do not identify as Muslim
* Women aged less than 25 years or older than 74 years
* Women who are up-to-date with all the screening they are eligible for
* Women who had either breast, cervical or bowel cancer before as their knowledge of the disease and treatment would differ from other women who do not have any prior experience with the disease
* Women who have had BReast CAncer gene testing and underwent mastectomy and/or hysterectomy

Conditions4

Bowel CancerBreast CancerCancerCervical Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.